CRISPR-Cas9: A potent gene-editing tool for the treatment of cancer
The prokaryotic adaptive immune system has clustered regularly interspaced short
palindromic repeat. CRISPR-associated protein (CRISPR-Cas) genome editing systems …
palindromic repeat. CRISPR-associated protein (CRISPR-Cas) genome editing systems …
[HTML][HTML] Clonal expansion and myeloid leukemia progression modeled by multiplex gene editing of murine hematopoietic progenitor cells
Highlights•We performed CRISPR/Cas9-mediated gene editing of a purified hematopoietic
stem cell (HSC) population.•Multiplex gene editing of HSCs causes clonal hematopoiesis …
stem cell (HSC) population.•Multiplex gene editing of HSCs causes clonal hematopoiesis …
CRISPR-Cas9 system: a novel and promising era of genotherapy for beta-hemoglobinopathies, hematological malignancy, and hemophilia
AM Alayoubi, ZY Khawaji, MA Mohammed… - Annals of …, 2024 - Springer
Gene therapy represents a significant potential to revolutionize the field of hematology with
applications in correcting genetic mutations, generating cell lines and animal models, and …
applications in correcting genetic mutations, generating cell lines and animal models, and …
Progress and application of CRISPR/Cas technology in biological and biomedical investigation
J Lin, Y Zhou, J Liu, J Chen, W Chen… - Journal of Cellular …, 2017 - Wiley Online Library
Based on the tremendous progress of the understanding on the CRISPR‐Cas systems, the
application CRISPR/Cas technology has been extended into increasing scenarios in …
application CRISPR/Cas technology has been extended into increasing scenarios in …
CRISPR/Cas9 editing of the genome for cancer modeling
A Guernet, L Grumolato - Methods, 2017 - Elsevier
The CRISPR/Cas9 revolution has democratized access to genome editing in many
biological fields, including cancer research. Cancer results from the multistep accumulation …
biological fields, including cancer research. Cancer results from the multistep accumulation …
The potential revolution of cancer treatment with CRISPR technology
D Stefanoudakis, N Kathuria-Prakash, AW Sun, M Abel… - Cancers, 2023 - mdpi.com
Simple Summary Clustered regularly interspaced short palindromic repeats (CRISPR)-
CRISPR associated protein (Cas) 9 is a novel technology utilized to modify target genes …
CRISPR associated protein (Cas) 9 is a novel technology utilized to modify target genes …
[HTML][HTML] Genome editing in cancer: Challenges and potential opportunities
D Breier, D Peer - Bioactive Materials, 2023 - Elsevier
Ever since its mechanism was discovered back in 2012, the CRISPR/Cas9 system have
revolutionized the field of genome editing. While at first it was seen as a therapeutic tool …
revolutionized the field of genome editing. While at first it was seen as a therapeutic tool …
[HTML][HTML] CRISPR/Cas: advances, limitations, and applications for precision cancer research
Y Yang, J Xu, S Ge, L Lai - Frontiers in medicine, 2021 - frontiersin.org
Cancer is one of the most leading causes of mortalities worldwide. It is caused by the
accumulation of genetic and epigenetic alterations in two types of genes: tumor suppressor …
accumulation of genetic and epigenetic alterations in two types of genes: tumor suppressor …
Genome editing approaches with CRISPR/Cas9 for cancer treatment: Critical appraisal of preclinical and clinical utility, challenges, and future research
S Chira, A Nutu, E Isacescu, C Bica, L Pop, C Ciocan… - Cells, 2022 - mdpi.com
The increasing burden on human malignant diseases became a major concern for
healthcare practitioners, that must deal with tumor relapse and the inability to efficiently treat …
healthcare practitioners, that must deal with tumor relapse and the inability to efficiently treat …
The rise of CRISPR/Cas for genome editing in stem cells
B Shui, L Hernandez Matias, Y Guo… - Stem cells …, 2016 - Wiley Online Library
Genetic manipulation is a powerful tool to establish the causal relationship between a
genetic lesion and a particular pathological phenotype. The rise of CRISPR/Cas9 genome …
genetic lesion and a particular pathological phenotype. The rise of CRISPR/Cas9 genome …